Loading, Please Wait...
MIAMI, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the FlyPharma US conference, an event aimed at connecting forward-thinking individuals and businesses to address trending topics in the pharma supply chain industry, taking place from Sept. 11-12 in Miami, Florida.
S. Parikh Mars , CEO of Progressive Care Inc., will be speaking on the “Global vs. Local” panel taking place from 9:50 a.m. – 10:40 a.m. on Wednesday, Sept. 12. Mars will be speaking alongside executives from American Airlines and Miami International Airport, among others. The panel will discuss the impact that local challenges can have on the global supply chain community and the possible solutions to consider. Mars will offer the perspective of the end-user in the global supply chain process, sharing her take on whether pharma hubs are a viable answer to support smaller businesses.
“We are proud to be participating at FlyPharma’s first U.S. event that connects leaders in the global pharma supply chain industry,” Mars said. “The conference’s theme of collaboration very much aligns with Progressive Care’s approach to offering innovative healthcare solutions for patients and physicians. It is an honor to represent the voice of the end-user’s role in the global supply chain process and we hope that this conversation fosters more new and improved relationships across the industry as a whole.”
The FlyPharma US conference is the newest addition to FlyPharma’s series of conferences in Asia and Europe. Collaboration and innovation are always core themes of the FlyPharma event series, with the theme of the US event focusing on “supply chain collaboration.” Learn more about the FlyPharma US 2018 conference by visiting http://www.flypharmaus.com/.
For more information about Progressive Care, please visit the company’s website.
The company will be sharing live updates, photos and videos from the conference on its social channels. To view these updates, follow the company on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Public Relations Contact:
Tory Patterson, CMW Media
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp